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Abstract
Diagnosis of Sjögren’s syndrome (SS) is complex and the usefulness of labial minor salivary glands biopsy in this 
process remains controversial. 
Objectives: to evaluate the clinical and laboratorial profile and histological features on labial minor salivary glands 
from patients under investigation of SS. 
Study Design: clinical charts from 38 patients under suspicion of SS and submitted to labial minor salivary glands 
biopsies were reviewed. Clinical and laboratorial data were retrieved from the clinical files and the HE-stained 
histological slides were reviewed under light microscopy. 
Results: mean age of the patients was 56.5 years and 97% were females; histological analysis showed that 42% of 
the cases showed ductal dilatation, lymphocytic foci were found in 52.6% and, from this group, 80% of the cases 
presented a foci/lobules ratio above 0.8. Acinar/ductal ratio was considered diminished in 39.5% of the samples. 
Thirty six (95%) and 32 (84%) patients, respectively, complained about xerostomia and xerophthalmia. A study of 
the time interval of the symptoms that led to SS investigation showed a mean of 116 months. Moreover, sixty-six 
percent of the patients had already been submitted to immunosuppressive therapy prior to the labial minor salivary 
gland biopsy. Age of the patients, scintigraphic alterations on salivary function, antinuclear factor (ANF), anti-Ro 
and anti-La did not show statistical significant association with the histological features. Lobules/foci ratio above 
0.8 was the only histological parameter statistically associated with Sjögren’s syndrome diagnosis (p<0.0001). 
Conclusions: in the studied sample, lymphocytic foci on salivary glands were the only histological parameter as-
sociated to the diagnosis of SS. Early indication of labial minor salivary gland biopsy to patients under investiga-
tion of SS could limit the effects of immunosuppressive therapy on the histological features associated with the 
evolution of salivary gland involvement in SS.
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Introduction
Sjögren’s syndrome (SS) is a chronic autoimmune dis-
ease characterized by xerophthalmia and xerostomia, 
functional alterations in both salivary and lacrimal 
glands and the presence of specific and unspecific se-
rum autoantibodies in the affected patients (1-4). Diag-
nosis of SS is complex and depends on subjective symp-
toms and clinical, serological and histological features, 
obtained through investigations performed by a multi-
disciplinary team, including rheumatologists, ophthal-
mologists, clinicians and dentists (5-7). Biopsy of labial 
minor salivary glands has been considered a diagnostic 
adjunctive technique with high specificity for SS, with 
few post surgical complications (8-10). Nevertheless, 
its regular use on SS diagnosis is not a routine at some 
reference centers, especially due to the need for care-
ful histological evaluation of the specimens and the in-
vasive nature of the procedure. The aim of the present 
study was to retrospectively evaluate the clinical and 
laboratorial parameters and the detailed histological 
features of labial minor salivary glands from a group of 
patients under investigation for SS.
Material and Methods
All specimens from biopsies directed to the removal 
of labial minor salivary glands performed in patients 
under investigation for Sjögren’s syndrome registered 
in the Oral Pathology laboratory, School of Dentistry, 
State University of Rio de Janeiro, from 2006 to 2009 
were reviewed. Histological slides containing hema-
toxylin and eosin (HE)-stained 5µm sections were 
analyzed under light microscopy (Eclipse E-200 mi-
croscope, Nikon, Japan), according to the following cri-
teria: number of salivary gland lobules; percentage of 
adipose tissue on the salivary glands (less than 10% or 
more than 10%); absence or presence of ductal dilata-
tion, acinar atrophy and sclerosis of the glandular con-
nective tissue; acinar/ductal ratio (normal ratio, similar 
to normal glands; reduced ratio, with increased ductal 
component); the number of lymphocytic foci (1 focus 
was composed of at least 50 grouped lymphocytes); and 
the ratio number of lobules/number of foci. The esta-
blished ratio as the limit between the groups considered 
“compatible” and “non-compatible” with the diagnosis 
of Sjögren’s syndrome was 0.8, which means the pre-
sence of at least 5 lymphocytic foci in 4 minor salivary 
gland lobules. This criterion was used in addition to the 
absolute number of lymphocytic foci due to the fact that 
in some cases the submitted specimens were constituted 
by less than 5 salivary gland lobules.
After selection and review of all HE-stained histological 
slides, clinical and laboratory information was retrieved 
from the clinical records of all patients on the Rheu-
matology service at Pedro Ernesto University Hospital, 
School of Medicine, State University of Rio de Janeiro. 
Data included age, gender, symptoms of xerostomia 
and xerophthalmia, results from the Schirmer tests and 
major salivary gland scintigraphy, history of recurrent 
parotitis, pulmonary involvement and presence of other 
concomitant rheumatoid autoimmune diseases. Serum 
laboratory data retrieved from the clinical records in-
cluded autoantibodies, such as rheumatoid factor (RF), 
ANF, anti-Ro and anti-La. Time interval with the symp-
toms that led to the investigation of Sjögren’s syndrome 
and history of previous/present immunosuppressive 
treatment before the labial minor salivary gland biopsies 
were also retrieved. Patients treated or under follow-up 
in other institutions, without clinical records present-
ing sufficient data for analysis, and showing HE-stained 
slides presenting no sufficient available tissue for his-
tological analysis were excluded from the final studied 
sample. Data were tabulated and analyzed with the aid 
of the Statistical Package for Social Science (SPSS ver-
sion 8.0, SPSS Inc., Chicago, Illinois, United States, 
1997) with statistical significance level of 5% (p<0.05). 
This study was approved by the Ethics Committee, State 
University of Rio de Janeiro (COEP 059/2010).
Results
Seventy-seven HE-stained histological slides contain-
ing labial minor salivary glands from patients under in-
vestigation of Sjögren’s syndrome were reviewed. From 
this initial sample, 38 cases presenting sufficient clinical 
and laboratory information were selected, representing 
the final studied sample. Patients from this group pre-
sented a mean age of 56.5 years (ranging from 30 to 78 
years) and 37 patients were females (97%). Histological 
analysis showed that 55.3% presented more than 10% of 
glandular adipose tissue and 42% of the cases showed 
ductal dilatation. Acinar atrophy and connective tissue 
sclerosis were found in 15.8% and 10.5% of the cases, 
respectively. Lymphocytic foci were found in 52.6% of 
the cases and, from this group, 80% of the cases pre-
sented a foci/lobules ratio above 0.8. Acinar/ductal ra-
tio was considered diminished in 39.5% of the samples. 
Figure 1 (A-D) shows some histological features from 
the affected minor salivary glands. 
Thirty six (95%) and 32 (84%) patients, respective-
ly, complained about xerostomia and xerophthalmia. 
Schirmer test was performed in 29 patients (76%), of 
which 18 (62%) showed results compatible with Sjö-
gren’s syndrome. Eight out of the 38 patients (21%) re-
ported previous episodes of recurrent parotitis and 20 
out of  the 33 patients (61%) submitted to salivary gland 
scintigraphy showed altered salivary function. Thirty 
two patients (84%) reported being diagnosed with other 
autoimmune diseases, especially rheumatoid arthritis, 
lupus erythematosus and fibromyalgia, and 5 patients 
(13%) reported associated pulmonary symptoms. Labo-
ratory exams showed that out of the 32 patients tested 
Med Oral Patol Oral Cir Bucal. 2014 May 1;19 (3):e237-41.                                                                                                                        Labial minor salivary gland biopsy in Sjögren’s syndrome
e239
for ANF, 17 (53%) showed positive results. In contrast, 
from the 24 patients who had been tested for RF, only 4 
(17%) showed positive results. Anti-Ro and anti-La were 
requested together for 24 patients and 9 (38%) showed 
positive results for both. Time interval with the symp-
toms that led to Sjögren’s syndrome investigation ranged 
from 1 to 288 months, with a mean of 116 months, and 25 
out of the 38 patients (66%) had already been submitted 
to immunosuppressive therapy prior to labial minor sali-
vary gland biopsy. Time interval from the beginning of 
the symptoms and the labial minor salivary gland biopsy 
ranged from 4 to 312 months, with a mean of 91 months.
Table 1 shows the distribution of the histological pa-
rameters according to age, results from the salivary 
Fig. 1. A-B) Minor salivary glands showing extensive lymphocytic infiltration, destruction of the 
acinar component and preservation of the ductal structures (HE, 10x); C) Focal lymphocytic infil-
tration characteristic of Sjögren’s syndrome (HE, 10x); D) Detail of the limit between the lympho-
cytic infiltrate and the preserved minor salivary gland acini (HE, 40x).  
Parameter 
Ductal
dilatation p
% Adipose 
tissue p
Acinar
atrophy p
Acinar/ductal
ratio p
Lobules/foci
ratio p
Yes No <10% >10% Yes No NL * DE * <0,8 >0,8 
Age (years) 
(n=38) 
< 55 12 5 0.197 11 6 0.342 14 3 0.778 12 5 0.326 9 8 0.743 
> 55 10 11  10 11  18 3  11 10  13 8  
Scintigraphy 
(n=33) 
+ 13 7 0.169 13 7 0.472 18 2 0.182 13 7 0.472 9 11 0.284 
- 5 8  6 7  9 4  6 7  9 4  
ANF ** 
(n=32) 
+ 11 6 0.287 11 6 0.720 12 5 0.178 10 7 0.946 8 9 0.305 
- 6 9  8 7  14 1  9 6  10 5  
RF *** 
(n=24) 
+ 3 1 0.590 1 3 0.272 2 2 0.179 0 4 0.020 0 4 0.093 
- 9 11  13 7  17 3  14 6  12 8  
Anti-Ro
(n=23) 
+ 5 3 0.673 4 4 0.685 7 1 0.955 4 4 0.182 4 4 0.657 
- 8 7  9 6  13 2  12 3  10 5  
Anti-La
(n=23) 
+ 4 1 0.339 2 3 0.618 4 1 0.539 3 2 0.621 2 3 0.343 
- 9 9  11 7  16 2  13 5  12 6  
Diagnosis SS 
**** (n=38) 
Yes 8 7 0.258 10 5 0.254 1 14 0.213 9 6 0.957 1 14 0.000 
No 8 15  11 12  5 18  14 9  21 2  
Table 1. Distribution of the histological features observed on labial minor salivary glands according to clinical and laboratorial parameters. 
* NL - normal, DE - decreased; ** ANF - antinuclear factor; *** RF - rheumatoid factor; **** SS - Sjögren’s syndrome.
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gland scintigraphy and laboratory parameters from the 
studied patients. Age of the patients, scintigraphic al-
terations on salivary function, ANF, anti-Ro and anti-
La did not show statistical significant association with 
the histological features. Although only 4 (17%) out of 
the 24 patients tested for RF presented positive results, 
all showed reduced acinar/ductal ration and lobules/foci 
ratio over 0.8 (Table 1). It was also observed that 12 out 
of the 25 patients (48%) under use of immunosuppres-
sant prior to labial biopsy showed a lobules/foci ratio 
over 0.8 and reduced acinar/ductal ratio. One third of 
the patients with negative results to anti-Ro and anti-La 
showed a lobules/foci ratio over 0.8, but the presence 
of anti-Ro and anti-La did not show statistical signifi-
cant association with the presence of lymphocytic foci 
(p=0.657 and 0.343, respectively).
Lobules/foci ratio above 0.8 was the only histological 
parameter statistically associated with Sjögren’s syn-
drome diagnosis (p<0.0001). Out of the 38 patients, 16 
(42%) showed lobules/foci ratio above 0.8, out of which 
14 were diagnosed with Sjögren’s syndrome after anal-
ysis of other criteria. One patient presented a lobules/
foci ratio lower than 0.8, but it was diagnosed with the 
syndrome due to the presence of other clinical and labo-
ratorial parameters. Two patients were not diagnosed 
with Sjögren’s syndrome, despite presenting a lobules/
foci ratio above 0.8, due to lack of confirmation after 
analysis of the other parameters (Table 1). 
Discussion
SS is a complex disease and diagnosis can be challeng-
ing in many cases. Depending on the country/region of 
origin of the study, SS can affect up 0.3 to 0.6% of the 
general population, with predilection for adult females 
on their 5th to 6th decades of life (2,3). It can be di-
agnosed as an isolated disease (primary SS) or asso-
ciated to other autoimmune diseases, such as rheuma-
toid arthritis and lupus erythematosus (associated SS) 
(11,12). SS etiology remains unknown, but combined 
genetic and environmental factors seem to participate 
in its pathogenesis (2). Several clinical, laboratorial, im-
aginological and histological parameters have proved to 
be useful in SS diagnosis, and two different classifica-
tion/diagnosis systems are currently being used for the 
disease, the American-European Consensus Group (13) 
and the Sjögren’s International Collaborative Clinical 
Alliance (14). Both have considered labial minor sali-
vary gland biopsy as a useful tool for SS diagnosis, due 
to the possibility of confirming the glandular damage 
and disease activity directly on the affected tissue. The 
present study focused on evaluating the association of 
clinical and laboratorial parameters with histological 
features in a subset of patients under investigation of 
SS. As expected, the profile of the sample was com-
posed of adult females, reinforcing the possibility that 
hormonal and genetic alterations can, at least partially, 
modulate the development of the disease (7).
Daniels et al. have recently reinforced the importance of 
labial minor salivary gland biopsy for SS diagnosis, due 
to its high specificity, allowing the analysis of disease 
activity directly on the target organ (9). Although some 
authors have considered labial minor salivary gland 
biopsy an invasive procedure, intraoperative problems 
and post-surgical sequelae are unusual (15). The most 
important limitation of the technique is the difficulty in 
establishing definite and objective histological diagnos-
tic criteria capable of adequately characterize the speci-
mens associated with SS. The pathologist’s individual 
subjective analysis can reveal considerable variability, 
even knowing that the presence of lymphocytic foci is 
considered the gold standard for SS diagnosis (9,16,17). 
Critical analysis of the detailed histological parameters is 
essential for the evaluation of their usefulness in SS diag-
nosis (18). The present study focused on the evaluation of 
some histological parameters observed in minor salivary 
glands derived from labial biopsies for SS diagnosis, but 
lymphocytic foci remained as the only statistically sig-
nificant histological feature. It was interesting to notice 
that all patients presenting positive RF showed a reduced 
acinar/ductal ratio and lobules/foci ratio above 0.8, but 
the low number of cases precludes any significance of 
these results. Analysis of a larger sample focusing on this 
parameter could offer new insights on this topic.
Another limitation of the affected salivary glands 
analysis is associated with the large time interval from 
the beginning of the symptoms and the biopsy. In the 
present study the time interval from the first symptoms 
and the biopsy showed a mean of 91 months, reinforcing 
this problem. Patients usually start immunosuppressive 
therapy aimed at the control of the main symptoms and 
complaints associated with the disease (especially in as-
sociated SS) during this time interval, and it is believed 
that some histological parameters could be altered by 
local and systemic effect of the drugs. Zandbelt et al., 
have reported alterations on the histological parameters 
in SS-affected minor salivary glands before and after 
corticosteroid therapy, additionally suggesting that labi-
al minor salivary gland biopsy can be useful in monitor-
ing activity of the disease (19). The results of the present 
study showed that most patients had been submitted to 
or were on immunosuppressive therapy when the biop-
sies were performed. Even so, almost half the patients 
presented reduced acinar/ductal ratio and lobules/foci 
ratio above 0.8, fulfilling the histological criteria of SS. 
It is possible to speculate that these values would have 
been higher if it were not for the interference of the im-
munosuppressive therapy.
The importance of serological autoantibodies, such as 
anti-Ro and anti-La, on SS diagnosis has been demon-
strated and, in the clinical practice, serological exams 
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usually precede labial minor salivary gland biopsy on 
routine SS diagnosis (13,15,20). The results of the present 
study showed that more than 50% of the cases tested for 
anti-Ro and anti-La presented negative results. However, 
about one third of such cases presented histological lym-
phocytic foci compatible with SS. This data reveals that 
without minor salivary gland biopsy, a high percentage 
of patients would remain underdiagnosed due to the lack 
of immunological criteria. These results are similar to the 
results from Langerman et al., which showed that only 
53% of the patients who presented serological positive re-
sults showed lymphocytic foci compatible with SS (18).
The most representative histological feature associated 
with SS is the presence of lymphocytic foci. Bookman et 
al., have recently demonstrated the correlation of glandu-
lar fibrosis and reduction on salivary flow in SS affected 
patients (21). In the samples analyzed in the present study, 
minor salivary gland connective tissue sclerosis as well as 
acinar atrophy, were found in solely 15.8% and 10.5% of 
the cases, respectively, restricting their correlation with the 
other parameters. It is important to point out that these his-
tological characteristics carry a variable subjective com-
ponent during evaluation, limiting their routine use as an 
auxiliary parameter on SS diagnosis and progression.
A large recent multicentric study including clinical and 
histological data from 1726 subjects have demonstrat-
ed a strong association between the presence of lym-
phocytic foci on the affected minor salivary glands and 
serological parameters (higher titers of ANF, RF, anti-
Ro and anti-La) and a weak correlation with subjective 
parameters, such as xerostomia and xerophthalmia (9). 
The results from the present study showed no associa-
tion of the clinical, serological and histological studied 
parameters. However, the limited number of cases and 
the long time interval for the indication of the labial mi-
nor salivary gland biopsy in some cases under SS inves-
tigation may have modulated the results.
In the studied sample, lymphocytic foci on salivary 
glands were the only histological parameter associated 
to the diagnosis of SS. Early indication of labial minor 
salivary gland biopsy to patients under investigation of 
SS could limit the effects of immunosuppressive thera-
py on the histological features associated with the evo-
lution of salivary gland involvement in SS.
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